StockNews.com began coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the insurance provider’s stock.
Oxbridge Re Stock Up 1.1 %
NASDAQ:OXBR opened at $2.74 on Wednesday. The firm’s fifty day simple moving average is $2.63 and its 200 day simple moving average is $2.40. The stock has a market cap of $16.55 million, a P/E ratio of -3.26 and a beta of 0.96. Oxbridge Re has a twelve month low of $0.87 and a twelve month high of $3.72.
Institutional Trading of Oxbridge Re
A hedge fund recently raised its stake in Oxbridge Re stock. Geode Capital Management LLC boosted its holdings in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 3.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 129,294 shares of the insurance provider’s stock after buying an additional 4,141 shares during the period. Geode Capital Management LLC owned 2.14% of Oxbridge Re worth $359,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- What is a buyback in stocks? A comprehensive guide for investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Investing In Automotive Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Stock Market Sectors: What Are They and How Many Are There?
- Time to Load Up on Home Builders?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.